FDA Drug Approval Notices Aggregator

💊 FDA Drug Approval Notices Aggregator is a powerful Apify Actor designed to discover, track, and collect drug approval records directly from the FDA's own public openFDA API. This tool provides comprehensive Drug Approval Notices Aggregator intelligence including approval/application number, drug name, sponsor company, latest approval date, and a direct link to the official FDA application record for any drug keyword. Whether you're building a pharmaceutical intelligence dashboard, tracking regulatory approvals, or conducting healthcare market research, the FDA Drug Approval Notices Aggregator delivers actionable Drug Approval Notices Aggregator insights efficiently.

With direct openFDA API access, brand/generic name search, automatic pagination with global deduplication, and reliable Apify Dataset delivery, the FDA Drug Approval Notices Aggregator ensures comprehensive Drug Approval Notices Aggregator coverage across any drug keyword. It focuses on key Drug Approval Notices Aggregator signals including sponsor company, approval date, and application number, making it an essential tool for pharmaceutical regulatory research.

---

📋 Table of Contents

• Features
• Data Source
• How It Works
• Input
• Output
• Technical Stack
• Data Fields
• Use Cases
• Quick Start
• Configuration
• Performance
• Important Notes
• License & Legal

---

🔥 Features

• Direct openFDA API Access – Queries the FDA's official openFDA Drugs@FDA API (api.fda.gov/drug/drugsfda.json) directly for fast, structured Drug Approval Notices Aggregator data.
• Brand & Generic Name Search – Matches keywords against both brand name and generic name fields in a single query.
• Latest Approval Date Extraction – Scans each application's submission history to surface the most recent approval ("AP") submission date.
• Automatic Pagination – Pages through all available results using skip/limit until the configured maximum is reached.
• Global Deduplication – Tracks seen application numbers to prevent duplicate entries in the output.
• Retry-Resilient Requests – Automatically retries on rate limits (429) and service unavailable (503) responses with backoff delays.
• 404-Safe Handling – Treats a 404 response as zero results rather than an error, keeping the run stable.
• Direct FDA Record Links – Builds a link to the official FDA application overview page for every result.
• Residential Proxy Support – Apify residential proxy for reliable Drug Approval Notices Aggregator access.
• Incremental Dataset Push – Pushes each batch of results to the Dataset as it's collected, not just at the end.

---

📊 Data Source

openFDA Drugs@FDA API

• Authority: The U.S. Food and Drug Administration's official openFDA platform (api.fda.gov/drug/drugsfda.json)
• Access Method: Browser-impersonated HTTP requests via curl_cffi, run through an executor for async compatibility
• Coverage: Any publicly listed drug application matching the given brand or generic name keyword
• Data: Structured JSON application records, including sponsor, submission history, and openFDA-normalized brand/generic names
• Access: Public API, no API key required for standard usage limits
• Update Frequency: Reflects the FDA's currently published Drugs@FDA dataset at time of run

---

⚙️ How It Works

The FDA Drug Approval Notices Aggregator accepts an optional drug keyword and builds an openFDA search query matching it against both the brand_name and generic_name fields. It then pages through the Drugs@FDA API using skip/limit pagination, retrying automatically on rate limits or service-unavailable responses with increasing backoff delays, and treating a 404 as an empty result set rather than a failure. For each returned application, the Actor extracts the application number, resolves a display drug name from the brand or generic name list, identifies the sponsor company, and scans the submission history for the most recent approval-status ("AP") submission date. A global set of seen application numbers prevents duplicates across pages. Each normalized record includes a direct link to the application's official FDA overview page, and results are pushed to the Apify Dataset incrementally as they're collected.

Key Processing Steps:

1. Input Parsing – Accept an optional drug keyword
2. Proxy Setup – Configure Apify residential proxy for the impersonated HTTP session
3. Query Construction – Build an openFDA search query matching brand and generic name fields
4. API Request – GET the Drugs@FDA endpoint with limit, skip, and the optional search query
5. Retry Handling – Back off and retry on rate limits (429) or service unavailable (503) responses
6. 404 Handling – Treat a 404 response as zero results rather than an error
7. Deduplication Check – Skip any application number already seen in a previous page
8. Application Normalization – Extract drug name, sponsor, latest approval date, and build the FDA record link
9. Pagination – Continue requesting subsequent pages using skip increments until results or the max cap are exhausted
10. Incremental Push – Push each batch of normalized results to the Dataset as it's ready
11. Rate Limiting – Apply a short delay between paginated requests

Key Benefits:

• Pull Drug Approval Notices Aggregator data for any drug keyword without manually searching openFDA
• Match both brand and generic drug names in a single search
• Track newly approved drugs and their sponsor companies
• Feed pharmaceutical intelligence dashboards, regulatory tracking tools, or market research pipelines
• Automate recurring Drug Approval Notices Aggregator checks as new approvals are published

---

📥 Input

The Actor accepts the following input parameters:

Field	Type	Default	Description
keywords / keyword	string	(none — all approvals)	Drug name (brand or generic) to search for.
proxyConfiguration	object	{"useApifyProxy": true, "apifyProxyGroups": ["RESIDENTIAL"]}	Apify proxy configuration for the search session.

Note: This Actor caps total results at 100 per run (MAX_RESULTS = 100), independent of any input field.

Example Input:

{
  "keywords": "ibuprofen",
  "proxyConfiguration": {
    "useApifyProxy": true,
    "apifyProxyGroups": ["RESIDENTIAL"]
  }
}

Search a Single Drug Name:

{
  "keyword": "atorvastatin"
}

Fetch General Recent Approvals (No Keyword):

{
  "keywords": ""
}

---

📤 Output

The Actor pushes Drug Approval Notices Aggregator records with the following structure:

Field	Type	Description
approval_id	string	The FDA application number
drug	string	The drug's brand name, falling back to generic name, or "Unknown Drug"
company	string	Name of the sponsor company
date	string	Most recent approval submission date, formatted as YYYY-MM-DD
link	string	Direct URL to the application's official FDA overview page
scraped_at	string	ISO 8601 timestamp of when the record was scraped

Example Drug Approval Notices Aggregator Record:

{
  "approval_id": "NDA021906",
  "drug": "Example Brand Tablets",
  "company": "Example Pharmaceuticals Inc.",
  "date": "2026-04-15",
  "link": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021906",
  "scraped_at": "2026-09-03T09:00:00+00:00"
}

---

🧰 Technical Stack

• HTTP Client: curl_cffi with Chrome impersonation for reliable access to the openFDA API
• Concurrency: asyncio with an executor bridge for running the impersonated client asynchronously
• Pattern Matching: re for stripping letter prefixes from application numbers when building FDA record links
• Date Handling: datetime with timezone-aware UTC timestamps
• Proxy: Apify Proxy with RESIDENTIAL configuration by default
• Logging: Apify Actor logging system
• Platform: Apify Actor serverless environment

---

📊 Data Fields Explained

Application Identity

• approval_id: The FDA-assigned application number (e.g., NDA, ANDA, BLA number)
• drug: The resolved display name, preferring brand name over generic name

Sponsor & Timing

• company: The pharmaceutical company sponsoring the application
• date: The most recent approval-status submission date found in the application's history

Access

• link: Direct link to the application's official overview page on the FDA's Drugs@FDA portal

---

🎯 Use Cases

• Pharmaceutical Intelligence – Track newly approved drugs and their sponsor companies
• Regulatory Monitoring – Stay current on FDA approval activity for a specific drug or company
• Investor Research – Monitor a pharma company's approval pipeline via sponsor name tracking
• Competitive Analysis – Track competitor drug approvals within a therapeutic category
• Academic Research – Study drug approval trends and timelines at scale
• Healthcare Journalism – Source primary approval data for pharmaceutical news coverage

---

🚀 Quick Start

1. Prepare Input

Go to Apify Console and enter:

{
  "keywords": "ibuprofen"
}

2. Run the Actor

Click Start. The Actor will:

• Search openFDA for applications matching the brand or generic name keyword
• Page through all matching results, retrying on rate limits automatically
• Deduplicate applications across pages
• Push batches to the Dataset incrementally as they're collected

3. Monitor Progress

Console shows:

🔎 Searching openFDA for Drug Keyword: 'ibuprofen'
Saved 25 approvals | Total: 25/100
🎉 Scraping complete! Successfully aggregated 25 FDA drug approval records.

4. View & Download Results

• Results Tab: All Drug Approval Notices Aggregator records
• Export: JSON, CSV, Excel, or HTML
• Filter: By company or approval date
• API Access: Available via the Apify API

---

⚙️ Configuration

Single drug keyword search:

{
  "keyword": "atorvastatin"
}

No keyword (general recent approvals):

{
  "keywords": ""
}

Custom proxy group:

{
  "keywords": "ibuprofen",
  "proxyConfiguration": {
    "useApifyProxy": true,
    "apifyProxyGroups": ["RESIDENTIAL"]
  }
}

---

📈 Performance

Processing Speed

• One or more paginated requests, capped at 100 total results per run
• 0.3 second delay between paginated requests to stay within fair-use expectations
• Automatic retry backoff (up to 3 attempts) on rate limits or service-unavailable responses

Resource Usage

• Memory: Low, since no browser instance is launched
• Network: Multiple lightweight JSON requests, scaling with result volume up to the 100-record cap
• Proxy: One residential proxy tunnel shared across the impersonated session for the run

---

⚠️ Important Notes

Legal & Compliance

• Fair Use: Applies pacing delays between paginated requests to the public openFDA API
• Public Data Only: Retrieves only publicly published FDA drug approval data already indexed by openFDA
• Legal: Not legal advice — consult qualified professionals before using this data for compliance-sensitive or medical decisions

Data Quality

• Freshness: Reflects openFDA's currently published Drugs@FDA dataset at time of run
• Completeness: date will be blank if no approval-status ("AP") submission is found in the application's history; drug defaults to "Unknown Drug" if no brand or generic name is available
• Accuracy: Sourced directly from the FDA's own openFDA API
• Verification: Cross-check high-stakes approval details against the live FDA Drugs@FDA website

Best Practices

• Use specific brand or generic drug names to keep result volume relevant
• Remember this Actor caps output at 100 results per run regardless of how many matches exist
• Re-run periodically to catch newly published approvals
• Treat "Unknown Drug" results as a signal to check the application's raw openFDA record directly
• Combine with sponsor-name searches for company-level pharmaceutical pipeline tracking

---

📄 License & Legal

Terms of Use:

• Use for legitimate research, regulatory monitoring, and pharmaceutical intelligence purposes
• Respect the FDA's openFDA Terms of Service
• Use Drug Approval Notices Aggregator data responsibly and in compliance with applicable laws
• Not a substitute for professional medical or regulatory advice

Disclaimer: FDA Drug Approval Notices Aggregator is provided as-is for research and analytics purposes. Users are responsible for compliance with the FDA's openFDA terms and all applicable laws. This is not legal or medical advice.

---

⚖️ Drug Approval Notices Aggregator Excellence

This Actor is optimized for Drug Approval Notices Aggregator research with:

• ✅ Direct, official openFDA API access — no HTML scraping fragility
• ✅ Combined brand and generic name search
• ✅ Retry-resilient requests with automatic backoff
• ✅ Global deduplication across paginated results
• ✅ Incremental Dataset push
• ✅ Production-ready code